Drug Detail
Information about Tremelimumab
Generic Name |
Tremelimumab | |
|---|---|---|
IND |
CP675.206 | |
Brand Name (US) |
||
Manufacturer |
AstraZeneca | |
Drug Type |
||
Delivery |
Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
Immune system | |
Strategy |
Immune checkpoint inhibitor | |
Drug Category |
CTLA-4 inhibitor | |